All News

The tislelizumab combination met the primary endpoint of OS in patients with programmed death ligand 1 (PD-L1) expression, with additional follow-up needed to assess OS benefits in the intention-to-treat population.

Pharmacy managers would do well to stay atop of literature and developments, but also learn to engage others within and outside of pharmacy in order to elicit their support and also acquire ideas.

Some study limitations include that follow-up data were missing for some patients who dropped out of the study during the follow-up stages and the timing of the follow-up echocardiograms were random and driven by preference versus standard protocol.

Ten quiz questions to assess your knowledge on common symptoms and treatments for glaucoma.

Kimmtrak found to be the first therapy to demonstrate a survival benefit for HLA-A*02:01–positive adult patients with unresectable or metastatic uveal melanoma.

A machine-learning method called XGBoost provided the highest overall accuracy, despite being the least complex model.

Even after some pharmacy school classes resumed in-person, students had myriad barriers and motivators to attending because of the COVID-19 pandemic.

Fungicure Medicated Anti-Fungal Wash helps eliminate common fungus that can attack healthy skin.

Efgartigimod alfa-fcab (Vyvgart) is a human immunoglobulin G1 antibody fragment indicated for the treatment of generalized myasthenia gravis.

Gliomas begin in the glial cells that surround nerve cells and help them function.

Pharmacists can offer guidance on proper use of therapies and encourage adherence to regimens.

These findings suggest people with indications for PrEP may confront an access barrier if they live in a state that restricts scope of practice, according to the study.

The kit helps detect SARS-CoV-2 RNA in nasopharyngeal, anterior nasal, mid-turbinate nasal or oropharyngeal swab specimens from individuals suspected of COVID-19 by their health care provider.

This month features asciminib (Scemblix), pilocarpine HCI ophthalmic solution (Vuity), and amphetamine (Dyanavel XR).

Data from 4 analyses show that individuals treated with the drug achieved non-inferior vision gains compared with aflibercept.

Both data sets confirm previously announced results showing that the boost protects against the variant.

Investigators say that the post-acute sequalae markers are Epstein-Barr virus (EBV) DNA levels in the blood, pre-existing types 2 diabetes, the presence of certain antibodies, and SARS-CoV-2 RNA levels in the blood.

The 2 drugs are the first small molecule JAK-1 inhibitors to be approved in the United States as treatment options for patients who are not responding to other therapies.

Investigators analyzed data to determine the outcomes and risk factors for severe cases and how individuals with inflammatory bowel disease are affected.

New study results show that there are more incidences of this inflammation of the heart muscle related to not being vaccinated than there are to the vaccine itself.

Having such a program spearheaded by pharmacists has helped show the public the vital roles that pharmacists play.

Nearly two-thirds of respondents had residual feelings of anxiety, depression, or PTSD after using prescription medications.

Early-stage melanomas at risk of spreading secrete the TGFβ2 growth factor, which causes the downregulation of the AMBRA1 and Loricrin proteins.

DerMend treats or prevents dry, rough, scaly, and itchy skin, as well as minor skin irritations.

Xyosted is indicated for conditions associated with a deficiency or absence of endogenous testosterone.

Symptoms of gingivitis include swollen or puffy gums, dusky red and dark red gums, gums that bleed easily, bad breath, receding, and tender gums.

In The Legal Prescription series with Ned Milenkovich, we discuss a set of important topics in the pharmacy landscape.

The research team conducted a systematic review to collect the available published evidence on the topic and then combined the results using a process called meta-analysis.

They are in a unique position to evaluate patients in their practice settings to improve health outcomes.

The FDA also expanded the pediatric emergency use authorization for remdesivir to include the treatment of non-hospitalized pediatric patients at high risk of disease progression.